搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
clrb
/
财务摘要
Cellectar Biosciences Inc
CLRB
添加自选
2.090
USD
-0.140
-6.28%
收盘 09-22 16:00(美东)
16.70M
总市值
亏损
市盈率 TTM
Cellectar Biosciences Inc
2.090
-0.140
-6.28%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
CLRB 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Cellectar Biosciences Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
16.70M
股息TTM
0.00
市盈率 TTM
-0.39
每股收益TTM
-5.39
营业收入
--
净利润
-44.58M
净资产收益率
-395.20%
总资产收益率
-153.46%
Cellectar Biosciences Inc 财报日历
最新发布
8月 13, 2026
每股收益 / 预测值
-0.57
/-0.48
营业收入 / 预测值
--
/0.00
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
83.27%
-0.57
68.99%
-1.33
23.50%
-1.29
87.43%
-1.41
-339.72%
-3.39
84.21%
-4.30
89.27%
-1.68
75.94%
-11.18
96.48%
-0.77
-19.14%
-27.24
28.23%
-15.71
--
-46.48
--
-21.90
--
-22.86
--
-21.88
--
--
--
--
--
--
--
--
--
--
净利润
-27.22%
-6.93M
14.39%
-5.65M
-124.81%
-5.30M
69.70%
-4.44M
-492.57%
-5.45M
75.21%
-6.60M
70.11%
-2.36M
16.30%
-14.66M
88.82%
-919.37K
-210.47%
-26.64M
-9.23%
-7.88M
-124.29%
-17.52M
-10.57%
-8.22M
-39.76%
-8.58M
-21.92%
-7.22M
-34.24%
-7.81M
-23.34%
-7.44M
3.42%
-6.14M
-63.71%
-5.92M
-48.84%
-5.82M
利润表
营业利润
-19.19%
-7.20M
9.48%
-5.79M
55.35%
-5.69M
63.60%
-4.85M
55.94%
-6.04M
46.67%
-6.40M
-1.57%
-12.74M
-41.58%
-13.33M
-65.22%
-13.70M
-37.86%
-12.00M
-69.05%
-12.55M
-20.45%
-9.41M
-11.55%
-8.29M
-41.77%
-8.71M
-25.31%
-7.42M
-34.29%
-7.82M
-23.34%
-7.44M
3.45%
-6.14M
-55.90%
-5.92M
-48.84%
-5.82M
净利润
-27.22%
-6.93M
14.39%
-5.65M
-124.81%
-5.30M
69.70%
-4.44M
-492.57%
-5.45M
75.21%
-6.60M
70.11%
-2.36M
16.30%
-14.66M
88.82%
-919.37K
-210.47%
-26.64M
-9.23%
-7.88M
-124.29%
-17.52M
-10.57%
-8.22M
-39.76%
-8.58M
-21.92%
-7.22M
-34.24%
-7.81M
-23.34%
-7.44M
3.42%
-6.14M
-63.71%
-5.92M
-48.84%
-5.82M
资产负债表
流动资产
176.42%
34.88M
-37.77%
9.27M
-42.11%
14.04M
-62.06%
13.62M
-54.78%
12.62M
-64.00%
14.89M
131.99%
24.25M
78.51%
35.90M
397.45%
27.91M
198.77%
41.37M
-49.08%
10.45M
7.19%
20.11M
-77.81%
5.61M
-55.90%
13.85M
-43.86%
20.53M
-54.68%
18.76M
-46.34%
25.29M
-42.29%
31.39M
-36.88%
36.57M
109.02%
41.39M
流动负债总额
-10.72%
5.24M
-19.05%
4.87M
-49.40%
4.75M
-75.82%
4.91M
-61.32%
5.87M
-62.99%
6.02M
-27.44%
9.39M
23.34%
20.31M
135.34%
15.17M
133.88%
16.27M
133.98%
12.94M
152.81%
16.47M
14.97%
6.45M
49.54%
6.96M
38.57%
5.53M
105.79%
6.52M
59.33%
5.61M
-7.34%
4.65M
11.99%
3.99M
-19.96%
3.17M
总资产
167.53%
36.64M
-30.68%
11.12M
-41.20%
14.98M
-60.78%
14.63M
-53.39%
13.70M
-62.61%
16.04M
110.96%
25.47M
73.05%
37.29M
351.44%
29.38M
189.17%
42.91M
-44.07%
12.08M
11.55%
21.55M
-74.86%
6.51M
-53.62%
14.84M
-41.97%
21.59M
-53.95%
19.32M
-45.76%
25.89M
-41.90%
31.99M
-36.58%
37.20M
102.71%
41.95M
总负债
8.66%
6.77M
-0.06%
6.40M
-48.36%
5.06M
-74.70%
5.25M
-60.13%
6.23M
-61.73%
6.41M
-27.06%
9.80M
22.15%
20.75M
123.93%
15.62M
123.11%
16.74M
120.83%
13.43M
158.54%
16.98M
22.42%
6.98M
56.95%
7.50M
46.33%
6.08M
95.05%
6.57M
51.77%
5.70M
-9.60%
4.78M
7.55%
4.16M
-24.71%
3.37M
总权益
300.05%
29.87M
-51.04%
4.72M
-36.73%
9.92M
-43.32%
9.38M
-45.75%
7.47M
-63.18%
9.64M
1256.06%
15.68M
262.30%
16.55M
3047.08%
13.76M
256.76%
26.17M
-108.74%
-1.36M
-64.18%
4.57M
-102.31%
-467.00K
-73.04%
7.33M
-53.07%
15.51M
-66.96%
12.75M
-54.09%
20.19M
-45.34%
27.21M
-39.69%
33.05M
137.83%
38.59M
现金流量表
经营净额
-17.49%
-6.01M
48.36%
-4.85M
60.19%
-4.34M
53.36%
-4.28M
63.82%
-5.12M
29.77%
-9.38M
-13.73%
-10.91M
-13.62%
-9.17M
-87.80%
-14.14M
-86.00%
-13.36M
-29.47%
-9.60M
-15.04%
-8.07M
-30.78%
-7.53M
-42.54%
-7.18M
-64.30%
-7.41M
-9.09%
-7.01M
16.27%
-5.76M
-6.04%
-5.04M
-16.60%
-4.51M
-83.58%
-6.43M
投资净额
--
0.00
--
-3.38K
90.41%
-5.88K
--
0.00
--
--
--
--
77.03%
-61.29K
100.00%
0.00
--
-21.28K
--
-21.63K
-126.34%
-266.76K
-8352.90%
-597.28K
100.00%
0.00
100.00%
0.00
9.16%
-117.86K
-73.91%
-7.07K
-839.00%
-70.98K
--
-30.07K
-653.86%
-129.74K
--
-4.06K
融资净额
1306.12%
31.66M
--
--
--
4.99M
-67.04%
5.79M
225137900.00%
2.25M
--
--
-100.00%
0.00
-21.94%
17.56M
--
1.00
1461648800.00%
43.85M
-95.41%
441.00K
--
22.50M
--
0.00
--
3.00
961065600.00%
9.61M
--
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
-1.00
100.00%
0.00
常见问题
Cellectar Biosciences Inc的流动资产是多少?
根据Cellectar Biosciences Inc的FY2025财报,流动资产为14.04M(同比变化-42.11)。
Cellectar Biosciences Inc的总资产是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的总资产为14.98M(同比变化-41.20)。
Cellectar Biosciences Inc的总负债是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的总负债为5.06M(同比变化-48.36)。
Cellectar Biosciences Inc的总权益是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的总权益为9.92M(同比变化-36.73)。
Cellectar Biosciences Inc的净营业收入是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的净营业收入为-22.98M(同比变化55.62)。
Cellectar Biosciences Inc的净投资是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的净投资为-5.88K(同比变化94.36)。
Cellectar Biosciences Inc的净融资是多少?
根据Cellectar Biosciences Inc的FY2025财报,Cellectar Biosciences Inc的净融资为13.03M(同比变化-78.78)。
Cellectar Biosciences Inc的每股收益(EPS)是多少?
根据Cellectar Biosciences Inc的FY2025财报,每股收益(EPS)为-8.35(同比变化77.12)。
Cellectar Biosciences Inc的净利润是多少?
根据Cellectar Biosciences Inc的FY2025财报,净利润为-21.79M(同比变化51.12)。
Cellectar Biosciences Inc的股东权益回报率(ROE)是多少?
根据Cellectar Biosciences Inc的FY2025财报,股东权益回报率(ROE)为-200.01(同比变化85.74)。
Cellectar Biosciences Inc的资产回报率(ROA)是多少?
根据Cellectar Biosciences Inc的FY2025财报,资产回报率(ROA)为-107.74(同比变化54.63)。
Cellectar Biosciences Inc的营业利润是多少?
根据Cellectar Biosciences Inc的FY2025财报,营业利润为-22.98M(同比变化55.62)。